Speaking at the FDA: A Patient's Perspective on CAR-T Warning Labels and Risk Communication

EVENT
Written By Laurie Adami

FDA document: Laurie provided formal patient testimony on CAR-T therapy, including her perspective on the agency's black box warning decision and the importance of presenting risk data in context for patients facing terminal illness.

PATIENT TESTIMONY
Laurie Adami
Previous

The CAR-T Veteran: Resilience, Remission, and a Mission to Help Others
Next

The Documentary That Gave Me Hope: How Emily Whitehead's Story Led Laurie to CAR-T